Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Jennifer L Saavedra v. Eli Lilly and Company
Case Number:
2:12-cv-09366
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
February 26, 2013
Eli Lilly Can't Escape Class Action Over Cymbalta Labeling
A California judge on Monday denied a bid by Eli Lilly & Co. to escape a proposed class action alleging inadequate labeling of the antidepressant Cymbalta, saying he could not decide at this stage of the litigation whether the company properly warned doctors of the drug's risks.
-
January 29, 2013
Lilly Fights Cymbalta 'Brain Zaps' Suit, Saying It Warned Docs
Eli Lilly & Co. on Monday pressed a California federal judge to toss a proposed class action from consumers who allege they experienced "brain zaps" and other side effects when trying to stop using antidepressant Cymbalta, saying it properly warned doctors of risks.
- ← Previous
- 1
- 2
- Next →